1h Free Analyst Time
The infectious disease diagnostics market is poised to grow by $13.94 billion during 2022-2026, accelerating at a CAGR of 6.7% during the forecast period. The report on the infectious disease diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of infectious diseases, the development of novel drugs, and the increasing adoption of POC.
The infectious disease diagnostics market analysis includes the end-user segment and geographic landscape.
The infectious disease diagnostics market is segmented as below:
By End-user
- Hospitals
- Labs
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the infectious disease diagnostics market covers the following areas:
- Infectious disease diagnostics market sizing
- Infectious disease diagnostics market forecast
- Infectious disease diagnostics market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Five Forces Analysis
5 Market Segmentation by End-user
6 Customer Landscape
7 Geographic Landscape
8 Drivers, Challenges, and Trends
9 Vendor Landscape
10 Vendor Analysis
11 Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global infectious disease diagnostics market: Abbott Laboratories, Becton Dickinson and Co., Bio Rad Laboratories Inc., bioMerieux SA, Danaher Corp., DiaSorin SpA, F. Hoffmann La Roche Ltd., Genetic Signatures Ltd., Grifols SA, Hologic Inc., Meridian Bioscience Inc., Meril Life Sciences Pvt. Ltd., OraSure Technologies Inc., PerkinElmer Inc., QIAGEN NV, Siemens AG, Sysmex Corp., Thermo Fisher Scientific Inc., Trinity Biotech Plc, and Vela Diagnostics.Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is increase in M and A.`
According to the report, one of the major drivers for this market is the increasing prevalence of infectious diseases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Becton Dickinson and Co.
- Bio Rad Laboratories Inc.
- bioMerieux SA
- Danaher Corp.
- DiaSorin SpA
- F. Hoffmann La Roche Ltd.
- Genetic Signatures Ltd.
- Grifols SA
- Hologic Inc.
- Meridian Bioscience Inc.
- Meril Life Sciences Pvt. Ltd.
- OraSure Technologies Inc.
- PerkinElmer Inc.
- QIAGEN NV
- Siemens AG
- Sysmex Corp.
- Thermo Fisher Scientific Inc.
- Trinity Biotech Plc
- Vela Diagnostics
